{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:26:03Z","timestamp":1780539963545,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hainan Province","doi-asserted-by":"crossref","award":["824RC517"],"award-info":[{"award-number":["824RC517"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Hainan Provincial Graduate Innovation Research project","award":["Qhys2023-450"],"award-info":[{"award-number":["Qhys2023-450"]}]},{"name":"the Hainan Province Science and Technology Special Foundation","award":["ZDYF2021SHFZ222"],"award-info":[{"award-number":["ZDYF2021SHFZ222"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460602"],"award-info":[{"award-number":["82460602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82560459"],"award-info":[{"award-number":["82560459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30207-x","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T19:26:54Z","timestamp":1764444414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["AFP promotes cancer multidrug resistance through activating PI3K\/Akt\/NF-\u03baB signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Siren","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"2","key":"30207_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/cancers15020533","volume":"15","author":"C Shen","year":"2023","unstructured":"Shen, C., Jiang, X., Li, M. & Luo, Y. Hepatitis virus and hepatocellular carcinoma: Recent advances. Cancers (Basel). 15(2), 533. https:\/\/doi.org\/10.3390\/cancers15020533 (2023).","journal-title":"Cancers (Basel)."},{"key":"30207_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128270","author":"E \u00d6stensson","year":"2015","unstructured":"\u00d6stensson, E. et al. Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23\u201360 years. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0128270 (2015).","journal-title":"PLoS ONE"},{"issue":"5","key":"30207_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/biom12050645","volume":"12","author":"S Khare","year":"2022","unstructured":"Khare, S., Khare, T., Ramanathan, R. & Ibdah, J. A. Hepatocellular carcinoma: The role of microRNAs. Biomolecules 12(5), 645. https:\/\/doi.org\/10.3390\/biom12050645 (2022).","journal-title":"Biomolecules"},{"key":"30207_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2147\/IJN.S349426","volume":"17","author":"Y Li","year":"2022","unstructured":"Li, Y., Zhang, R., Xu, Z. & Wang, Z. Advances in nanoliposomes for the diagnosis and treatment of liver cancer. Int. J. Nanomed. 17, 909\u2013925. https:\/\/doi.org\/10.2147\/IJN.S349426 (2022).","journal-title":"Int. J. Nanomed."},{"key":"30207_CR5","doi-asserted-by":"publisher","first-page":"1093549","DOI":"10.3389\/fgene.2022.1093549","volume":"13","author":"S Wu","year":"2023","unstructured":"Wu, S. et al. Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity. Front Genet. 13, 1093549. https:\/\/doi.org\/10.3389\/fgene.2022.1093549 (2023).","journal-title":"Front Genet."},{"issue":"3","key":"30207_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/ijms18030547","volume":"18","author":"A Russo","year":"2017","unstructured":"Russo, A., Saide, A., Smaldone, S., Faraonio, R. & Russo, G. Role of uL3 in multidrug resistance in p53-mutated lung cancer cells. Int. J. Mol. Sci. 18(3), 547. https:\/\/doi.org\/10.3390\/ijms18030547 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"30207_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.883297","author":"M Jovanovi\u0107","year":"2022","unstructured":"Jovanovi\u0107, M., Podolski-Reni\u0107, A., Krasavin, M. & Pe\u0161i\u0107, M. The role of the thioredoxin detoxification system in cancer progression and resistance. Front Mol. Biosci. https:\/\/doi.org\/10.3389\/fmolb.2022.883297 (2022).","journal-title":"Front Mol. Biosci."},{"key":"30207_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.607275","author":"ZN Lei","year":"2020","unstructured":"Lei, Z. N. et al. Establishment and characterization of a Topotecan resistant non-small cell lung cancer NCI-H460\/TPT10 cell line. Front Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2020.607275 (2020).","journal-title":"Front Cell Dev. Biol."},{"issue":"16","key":"30207_CR9","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.3390\/ijms20163919","volume":"20","author":"S Feder","year":"2019","unstructured":"Feder, S., Kandulski, A., Schacherer, D., Weiss, T. S. & Buechler, C. Serum chemerin does not differentiate colorectal liver metastases from hepatocellular carcinoma. Int. J. Mol. Sci. 20(16), 3919. https:\/\/doi.org\/10.3390\/ijms20163919 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"30207_CR10","first-page":"1899","volume":"12","author":"W Teng","year":"2022","unstructured":"Teng, W. et al. Combination of CRAFITY score with alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma. Am. J. Cancer Res. 12(4), 1899\u20131911 (2022).","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"30207_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/cancers14020419","volume":"14","author":"T Shimamura","year":"2022","unstructured":"Shimamura, T., Goto, R., Watanabe, M., Kawamura, N. & Takada, Y. Liver transplantation for hepatocellular carcinoma: How should we improve the thresholds?. Cancers (Basel). 14(2), 419. https:\/\/doi.org\/10.3390\/cancers14020419 (2022).","journal-title":"Cancers (Basel)."},{"key":"30207_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70722","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. HBx Drives Liver Cancer Stem Cell Generation Through Stimulating Glucose Metabolic Reprogramming. J. Cell. Mol. Med. https:\/\/doi.org\/10.1111\/jcmm.70722 (2025).","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"30207_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jcmm.12745","volume":"20","author":"Y Lu","year":"2016","unstructured":"Lu, Y. et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J. Cell Mol. Med. 20(3), 549\u2013558. https:\/\/doi.org\/10.1111\/jcmm.12745 (2016).","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"30207_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40659-019-0242-7","volume":"52","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity. Biol Res. 52(1), 36. https:\/\/doi.org\/10.1186\/s40659-019-0242-7 (2019).","journal-title":"Biol Res."},{"key":"30207_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100976","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. Drug Resist. Updat. https:\/\/doi.org\/10.1016\/j.drup.2023.100976 (2023).","journal-title":"Drug Resist. Updat."},{"issue":"10","key":"30207_CR16","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3389\/fphys.2019.01621","volume":"29","author":"Y Zeng","year":"2020","unstructured":"Zeng, Y., Cui, Z., Liu, J., Chen, J. & Tang, S. MicroRNA-29b-3p Promotes Human Retinal Microvascular Endothelial Cell Apoptosis via Blocking SIRT1 in Diabetic Retinopathy. Front Physiol. 29(10), 1621. https:\/\/doi.org\/10.3389\/fphys.2019.01621 (2020).","journal-title":"Front Physiol."},{"issue":"1","key":"30207_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-024-01963-5","volume":"9","author":"Q Shan","year":"2024","unstructured":"Shan, Q. et al. The p-MYH9\/USP22\/HIF-1\u03b1 axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. Signal. Transd. Target Ther. 9(1), 249. https:\/\/doi.org\/10.1038\/s41392-024-01963-5 (2024).","journal-title":"Signal. Transd. Target Ther."},{"issue":"2","key":"30207_CR18","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1021\/acsnano.1c09864","volume":"16","author":"X Yin","year":"2022","unstructured":"Yin, X. et al. Serum metabolic fingerprints on bowl-shaped submicroreactor chip for chemotherapy monitoring. ACS Nano 16(2), 2852\u20132865. https:\/\/doi.org\/10.1021\/acsnano.1c09864 (2022).","journal-title":"ACS Nano"},{"issue":"11","key":"30207_CR19","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3390\/pharmaceutics13111891","volume":"13","author":"SJ Winter","year":"2021","unstructured":"Winter, S. J., Miller, H. A. & Steinbach-Rankins, J. M. Multicellular ovarian cancer model for evaluation of nanovector delivery in ascites and metastatic environments. Pharmaceutics. 13(11), 1891. https:\/\/doi.org\/10.3390\/pharmaceutics13111891 (2021).","journal-title":"Pharmaceutics."},{"key":"30207_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102240","author":"Y Pan","year":"2024","unstructured":"Pan, Y. et al. AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane. Transl. Oncol. https:\/\/doi.org\/10.1016\/j.tranon.2024.102240 (2024).","journal-title":"Transl. Oncol."},{"issue":"4","key":"30207_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41416-019-0513-7","volume":"121","author":"R Montal","year":"2019","unstructured":"Montal, R. et al. Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. Br. J. Cancer. 121(4), 340\u2013343. https:\/\/doi.org\/10.1038\/s41416-019-0513-7 (2019).","journal-title":"Br. J. Cancer."},{"issue":"2","key":"30207_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10408360601003143","volume":"44","author":"A Sarandakou","year":"2007","unstructured":"Sarandakou, A., Protonotariou, E. & Rizos, D. Tumor markers in biological fluids associated with pregnancy. Crit. Rev. Clin. Lab. Sci. 44(2), 151\u2013178. https:\/\/doi.org\/10.1080\/10408360601003143 (2007).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"2","key":"30207_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37155\/2717-5278-2021-03-02-1","volume":"3","author":"X Shan","year":"2021","unstructured":"Shan, X., Zhang, M., Lin, H., Zhu, M. & Li, M. Alpha-fetoprotein Promotes the Malignant Phenotype of Hepatocellular Carcinoma Cells: the Drugs Resistance Origination. Trends Oncol. 3(2), 1\u201318. https:\/\/doi.org\/10.37155\/2717-5278-2021-03-02-1 (2021).","journal-title":"Trends Oncol."},{"issue":"3","key":"30207_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ijc.25373","volume":"128","author":"M Li","year":"2011","unstructured":"Li, M. et al. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K\/AKT signaling in human hepatoma cell lines. Int. J. Cancer. 128(3), 524\u2013532. https:\/\/doi.org\/10.1002\/ijc.25373 (2011).","journal-title":"Int. J. Cancer."},{"issue":"12","key":"30207_CR25","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1016\/j.bmcl.2016.04.064","volume":"26","author":"E Dom\u00ednguez-\u00c1lvarez","year":"2016","unstructured":"Dom\u00ednguez-\u00c1lvarez, E. et al. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance. Bioorg. Med. Chem. Lett. 26(12), 2821\u20132824. https:\/\/doi.org\/10.1016\/j.bmcl.2016.04.064 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"30207_CR26","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.1038\/s41598-020-64400-x","volume":"10","author":"R Nasr","year":"2020","unstructured":"Nasr, R. et al. Molecular analysis of the massive GSH transport mechanism mediated by the human multidrug resistant protein 1\/ABCC1. Sci. Rep. 10(1), 7616. https:\/\/doi.org\/10.1038\/s41598-020-64400-x (2020).","journal-title":"Sci. Rep."},{"issue":"10","key":"30207_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41419-018-1036-5","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K\/AKT\/mTOR signalling. Cell Death Dis. 9(10), 1027. https:\/\/doi.org\/10.1038\/s41419-018-1036-5 (2018).","journal-title":"Cell Death Dis."},{"issue":"2","key":"30207_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2012.11.042","volume":"330","author":"M Li","year":"2013","unstructured":"Li, M. et al. Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis. Cancer Lett. 330(2), 170\u2013180. https:\/\/doi.org\/10.1016\/j.canlet.2012.11.042 (2013).","journal-title":"Cancer Lett."},{"issue":"7","key":"30207_CR29","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/ijc.30850","volume":"141","author":"B Lin","year":"2017","unstructured":"Lin, B. et al. Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells. Int. J. Cancer. 141(7), 1413\u20131421. https:\/\/doi.org\/10.1002\/ijc.30850 (2017).","journal-title":"Int. J. Cancer."},{"issue":"8","key":"30207_CR30","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/cancers13081792","volume":"13","author":"D Manna","year":"2021","unstructured":"Manna, D. & Sarkar, D. Multifunctional role of astrocyte elevated gene-1 (AEG-1) in cancer: Focus on drug resistance. Cancers (Basel). 13(8), 1792. https:\/\/doi.org\/10.3390\/cancers13081792 (2021).","journal-title":"Cancers (Basel)."},{"issue":"9","key":"30207_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu, R. et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 11(9), 797. https:\/\/doi.org\/10.1038\/s41419-020-02998-6 (2020).","journal-title":"Cell Death Dis."},{"issue":"8","key":"30207_CR32","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","volume":"28","author":"AX Zhu","year":"2022","unstructured":"Zhu, A. X. et al. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat. Med. 28(8), 1599\u20131611. https:\/\/doi.org\/10.1038\/s41591-022-01868-2 (2022).","journal-title":"Nat. Med."},{"issue":"4","key":"30207_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12032-025-02644-1","volume":"42","author":"S Wang","year":"2025","unstructured":"Wang, S. et al. FBXO32 ubiquitination of SUFU promotes progression and lenvatinib resistance in hepatocellular carcinoma via hedgehog signaling. Med. Oncol. 42(4), 98. https:\/\/doi.org\/10.1007\/s12032-025-02644-1 (2025).","journal-title":"Med. Oncol."},{"issue":"7\u20138","key":"30207_CR34","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10495-024-01967-0","volume":"29","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K\/AKT\/p53 signaling axis. Apoptosis 29(7\u20138), 1161\u20131184. https:\/\/doi.org\/10.1007\/s10495-024-01967-0 (2024).","journal-title":"Apoptosis"},{"issue":"7","key":"30207_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111194","volume":"40","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway. Cell Rep. 40(7), 111194. https:\/\/doi.org\/10.1016\/j.celrep.2022.111194 (2022).","journal-title":"Cell Rep."},{"issue":"5","key":"30207_CR36","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.gendis.2022.10.021","volume":"10","author":"X Zhai","year":"2022","unstructured":"Zhai, X. et al. LRP1B suppresses HCC progression through the NCSTN\/PI3K\/AKT signaling axis and affects doxorubicin resistance. Genes Dis. 10(5), 2082\u20132096. https:\/\/doi.org\/10.1016\/j.gendis.2022.10.021 (2022).","journal-title":"Genes Dis."},{"issue":"1","key":"30207_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40170-023-00311-5","volume":"11","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. A feedback loop of PPP and PI3K\/AKT signal pathway drives regorafenib-resistance in HCC. Cancer Metab. 11(1), 27. https:\/\/doi.org\/10.1186\/s40170-023-00311-5 (2023).","journal-title":"Cancer Metab."},{"issue":"5","key":"30207_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4149\/neo_2024_240511N214","volume":"71","author":"J Li","year":"2024","unstructured":"Li, J., Cheng, X., Huang, D. & Cui, R. Six2 regulates the malignant progression and 5-FU resistance of hepatocellular carcinoma through the PI3K\/AKT\/mTOR pathway and DNMT1\/E-cadherin methylation mechanism. Neoplasma 71(5), 451\u2013462. https:\/\/doi.org\/10.4149\/neo_2024_240511N214 (2024).","journal-title":"Neoplasma"},{"issue":"1","key":"30207_CR39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41420-024-02036-w","volume":"10","author":"LM Bomfim","year":"2024","unstructured":"Bomfim, L. M. et al. Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-kappaB and Akt\/mTOR signaling. Cell Death Discov. 10(1), 270. https:\/\/doi.org\/10.1038\/s41420-024-02036-w (2024).","journal-title":"Cell Death Discov."},{"issue":"3","key":"30207_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1166\/jbn.2022.3279","volume":"18","author":"S Zhou","year":"2022","unstructured":"Zhou, S., Ma, Y., Xu, R. & Tang, X. Nanoparticles loaded with GSK1059615 combined with sorafenib inhibited programmed cell death 1 ligand 1 expression by negatively regulating the PI3K\/Akt\/NF-kappaB pathway, thereby reversing the drug resistance of hepatocellular carcinoma to sorafenib. J. Biomed. Nanotechnol. 18(3), 693\u2013704. https:\/\/doi.org\/10.1166\/jbn.2022.3279 (2022).","journal-title":"J. Biomed. Nanotechnol."},{"key":"30207_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.115767","volume":"228","author":"R Gupta","year":"2023","unstructured":"Gupta, R. et al. Multifaceted role of NF-kappaB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches. Environ. Res. 228, 115767. https:\/\/doi.org\/10.1016\/j.envres.2023.115767 (2023).","journal-title":"Environ. Res."},{"issue":"1","key":"30207_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41419-025-07470-x","volume":"16","author":"B Yan","year":"2025","unstructured":"Yan, B. et al. CD146 regulates the stemness and chemoresistance of hepatocellular carcinoma via JAG2-NOTCH signaling. Cell Death Dis. 16(1), 150. https:\/\/doi.org\/10.1038\/s41419-025-07470-x (2025).","journal-title":"Cell Death Dis."},{"key":"30207_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106553","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh, M. D. A. et al. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacol. Res. https:\/\/doi.org\/10.1016\/j.phrs.2022.106553 (2023).","journal-title":"Pharmacol. Res."},{"key":"30207_CR44","doi-asserted-by":"publisher","first-page":"9327512","DOI":"10.1155\/2020\/9327512","volume":"2020","author":"QT Li","year":"2020","unstructured":"Li, Q. T. et al. Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-\u03baB (p65) Pathway in Hepatocellular Carcinoma Cells. J. Oncol. 2020, 9327512. https:\/\/doi.org\/10.1155\/2020\/9327512 (2020).","journal-title":"J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30207-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30207-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30207-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:40:12Z","timestamp":1767706812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30207-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30207"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30207-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"590"}}